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Abstract: 
Background: Researchers remain divided on the major causes of active 
surveillance (AS) drop-out; with rates as up to 38% in men with no evidence 
of disease progression.  
Objective: To develop and evaluate the value of an educational intervention 
on adherence to AS in men with low-intermediate risk prostate cancer (PC).  
Design, Setting and Participants: We carried out focus group discussions with 
men who had remained on and dropped out of AS to inform an intervention to 
increase adherence to AS. 255 consecutive men who had selected AS were 
recruited to either standard care (written information and access to a nurse 
specialist) or standard care and intervention. 
Intervention: An educational seminar was designed by patients and clinicians 
including information on imaging, biopsy techniques, understanding 
pathology, large AS cohorts - mortality and morbidity risk and diet and lifestyle 
advice. 
Outcome Measurements and Statistical Analysis: Proportions dropping out of 
AS for reasons other than disease progression were assessed, at 1 and 5 
years from AS selection using multivariate logistic regression.  
Results and Limitation: Common themes were found to influence men’s 
decision making on AS: (1) Clinical consistency (2) Information (3) Lifestyle 
advice.  
The addition of an educational seminar led to significantly fewer men dropping 
out of AS at 1 and 5 years, from 25% and 42% respectively in the standard 
care group to 11% and 22% (p=0.001) in the standard care plus seminar 
group.18 men in the intervention group failed to attend the seminar.  
Conclusion: The AS drop-out rate was halved following a single educational 
seminar delivered to groups of men with intermediate or low risk PC, even at 
5 years. 
Patient Summary: Men on AS feel more supported when being provided with 
an educational seminar within three months of treatment choice; halving the 
number of men dropping-out of AS, even at 5 years.  
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1.0 Introduction 
European guidelines suggest a large proportion of men with localized, low-risk 
prostate cancer (LRPC) do not require immediate treatment, but can be 
monitored – an approach known as active surveillance (AS) [1]. However, 
international variation in determinants for safe AS inclusion and follow-up [2] 
continue to contribute to high AS drop-out rates (up to 38%) in men with no 
evidence of disease progression [3].  
 
Researchers remain divided on the major causes of AS drop-out. A recent 
systematic review of AS choice and adherence literature [4] reported six 
domains driving unnecessary AS drop-out:  (1) patient characteristics; (2) 
tumour characteristics; (3) family and social support ; (4) provider; (5) 
healthcare organisation; and (6) health policy.  
 
However, informational interventions aimed at men on AS have widely 
reported a favourable impact on AS adherence. Oliffe [5] found that self-
management strategies helped men cope with some of the long-term 
uncertainty of AS, whilst ‘The Prostate Cancer Lifestyle Trial’ based on 
lifestyle modifications, including exercise and attention to stress management, 
demonstrated an improved treatment-free survival on AS [6].   Goh [7] found 
that men who perceived that they were receiving useful and consistent 
information were more satisfied with AS and therefore more likely to continue 
on AS whilst the UK based ProtecT Trial [8] found merit in consistency of 
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personnel to support and inform patients.  Interventions relating to peer 
support have also demonstrated a significant improvement in the quality of life 
of men with any stage of PC [8, 9]. 
 
Here we describe the development and evaluation of an intervention using a 
standardised information and support delivery technique which aims to 
increase AS adherence based on previous research efforts and local focus 
groups. 
 
2.0 Patients and methods 
This applied research project consisted of two parts: (1) Focus groups (FGs) 
to understand motivation and needs of men on AS and to explore 
practicalities of an intervention to support AS adherence; (2) Pilot intervention 
study to assess effect.  
 
2.1 Focus groups 
Permission was obtained from the local Urology audit committee to identify 
potential participants through electronic records (No:U13887). In December 
2009 and April 2010, two FGs were facilitated by the Clinical Nurse Specialist 
(CNS) team. The first consisted of eight men who were currently on AS and 
the second of seven men who had dropped out of AS without evidence of 
progression. A semi-structured question guide was developed to provide 
structure for each FG (Appendix 1), based on a review of the available 
literature at this time [10].  
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We employed thematic analysis, an inductive process designed to identify and 
examine emerging themes from conceptual data [11]. Thematic saturation in 
qualitative data has been reported at 15 (interview studies) [12] and therefore 
two FGs were scheduled. Purposive homogenous sampling was employed to 
provide conceptual significance to the question of adherence [13].  
 
2.2 Developing the Intervention (Educational Seminar) 
The intervention was developed in line with recommendations from the FGs.  
A power-point presentation was co-authored by patients, nurses, and doctors 
with final ratification by the AS reference group (4 partners of, and 10 men 
currently on or previously on AS).  
 
The proposed 1.5 hour seminar included information on: imaging, biopsy 
techniques, understanding pathology, large AS cohorts - mortality and 
morbidity risk and diet and lifestyle advice. Optimal seminar delivery was 
defined as a team approach: urologist and CNS. Time was scheduled at the 
end of the seminar for questions and peer group discussion.  
 
2.3 Recruitment 
We employed a method of consecutive sampling [14] appropriate to a process 
of service improvement where a standard of care is evaluated both prior and 
after intervention. The inclusion criteria was men diagnosed with low-
intermediate risk PC (as defined by the D’Amico classification system [15] 
appendix 1), suitable for AS based on information from Magnetic Resonance 
Imaging (MRI) and transrectal prostate biopsy with confirmatory transperineal 
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prostate biopsy. The AS progression criteria was, >G3+4 (transperineal 
biopsy approach - minimum 24 cores) or where the maximum contiguous 
cancer length was 6mm, >MRI - T2b, 30% of cores positive. Follow-up was 
carried out according to NICE guidelines (Appendix 2). 
 
Between January 2011 and June 2011, 135 men were recruited (Group A), 
and offered standard care (NICE [16]: introduction to a CNS and written 
information on AS (PCUK [17]). A second consecutive group recruited 
between July 2011 and December 2011 (Group B) included 120 men who 
were offered standard care and participation in the educational seminar. 
 
This study compared AS drop-out rates at 1 and 5 years post diagnosis. 
Patient and clinical characteristics at diagnosis, and outcomes were 
compared between both groups using descriptive statistics. Multivariate 
logistic regression, adjusting for age, grade, diagnostic PSA, digital rectal 
examination and clinical stage examined whether differences in drop-out rates 
were independent of patient characteristics.  
 
3.0 Results 
3.1 Qualitative analysis 
3.1.1 Designing the intervention: FGs  
The themes emerging from the two FGs were (1) consistency in clinical team, 
administration and follow-up protocol, (2) consistent information re: PC and 
AS, (3) diet and lifestyle advice. 
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(1) Clinical consistency (Panels 1 & 2) 
In both FGs, men described importance of a consistent approach to follow-up 
as well as familiarity with the clinical team. 
 
Men still on AS found reassurance: “my CNS always sees me for my PSA 
review, I have a great relationship with her, I could ask her anything”.  
 
Men in the group that had dropped out of AS described their experience as 
stressful: “nobody could give me any guarantees abot AS follow-up, every 
guideline seemed to be different. It made me very nervous”. They also 
described inconsistencies in the clinical team as: “very difficult”.  
 
(2)  Consistent information (panels 3 & 4) 
The two FGs differed in their response to the information given during AS. 
Those who had remained on AS felt that the amount of information given was 
adequate: “I was given some information leaflets by my CNS. I thought they 
were very good”.  The men who had dropped out of AS described the 
information as inconsistent: “every time I saw a new doctor or nurse I would 
question them about PC and AS. Sometimes the answers were the same, 
other times they sounded like they didn’t know what they were talking about”.  
 
(3) Diet and lifestyle advice (panels 5 & 6) 
Men remaining on AS described self-help as a major contributor to their 
quality of life. “I found lots of information on the internet about diet and 
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exercise. I changed my diet and began to go to the gym. I think everyone who 
has cancer should be aware. I’ve never felt better”.  
 
Men who had opted out of AS suggested that: “there really wasn’t any 
information on how I might help myself on AS” and “I don’t think the nurses or 
doctors believed that diet, exercise or complimentary treatments would help 
on AS. I might have stayed on AS if I’d had the opportunity to discuss this”.   
 
3.1.2 Developing the intervention  
The FGs discussed the medium through which the information and support 
should be given: website, bespoke written information, webinar and peer-
group seminar.  Men who had dropped out of AS described their experience 
of websites and on-line forums as “cold”. The men who had remained on AS, 
felt that websites gave no opportunity for feedback and that the forums, 
although interactive in some cases, were “extreme and unpoliced”.  There 
was universal agreement that the content of the intervention should be 
empowering, with an emphasis on self-care. Thirteen of fifteen participants 
agreed that a peer group one-off educational seminar would suit the needs of 
the majority, with an option to re-attend when/if required. The seminar was 
suggested to be held within three months of choosing AS to mirror the early 
support and information that men undergoing radical treatment received. 
 
It was also suggested that the content of the seminar had to be similar to our 
program of seminars offered to men undergoing prostatectomy and 
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radiotherapy [18]. Five topics were agreed on: Imaging, biopsy techniques, 
pathology, mortality and morbidity risk in AS and dietary and lifestyle advice.  
 
3.2  Quantitative analysis  
3.2.1 Patient demographics  
273 men were recruited to the study. 18 men in the intervention group failed 
to attend the seminar and were therefore omitted from the final analysis. This 
left 255 men, 135 in group A and 120 in group B (Figure 1).   
 
No statistically significant differences were found between the two groups for 
age, PSA and DRE clinical stage at study entry (Table 1). A statistically 
significant difference was, however, found in relation to Gleason grade group 
(GGG):  42 men (31%) in group A compared to 111 (93%) in group B with 
GGG1. 93 men (69%) in group A and 9 men (7%) in group B were diagnosed 
with GGG2. This was felt to be most likely associated with an increase in 
confidence for local AS monitoring practice in the intermediate PC risk group 
[19].  
 
3.2.2  Adherence to AS 
No men demonstrated clinical disease progression in the first year.  However, 
25% of group A compared to 11% in group B did drop out of AS (Table 2) 
(p=0.003).  
 
By year 5, patients in group B remained less likely to drop out of AS. Drop-out 
without evidence of progression was 21.7% in group B compared to 41.5% in 
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group A (p<0.001) (Table 2). Due to the  difference in clinical characteristics 
between the two groups, at 5 years following diagnosis the AS drop-out rate 
due to cancer progression was higher in group B than in group A, 21.7% 
versus 12.6% [20, 21].  
 
Drop-out rates remained significantly lower among seminar participants, after 
adjustment for baseline clinical characteristics, including GGG, at both 1 year 
(OR = 0.21, 95% CI 0.09-0.49) and 5 years (OR=0.26, 95% CI 0.12-0.56) 
(Table 3). Identical results were found when restricting the analysis to GGG1 
with an odds ratio of 0.25 (0.11-0.53) for drop out in patients without evidence 
of disease progression at 5 years. 
 
4.0 Discussion  
This is the first mixed methods study to develop and assess impact of an 
educational/supportive intervention on AS adherence over a 5 year period.  
Our findings demonstrated effectiveness of a structured, interactive, 
educational seminar in increasing adherence to AS for men with low-
intermediate risk PC.  
 
The needs of men requiring radical treatments for PC have been examined 
previously and have helped to define and develop the role of the CNS in 
supporting patients [22]. However, less is known about the resources and 
requirements of men selecting AS or engaging in long-term AS. A recent 
qualitative study suggested six requirements of men on AS [23]: (1) general 
information on PC and how to interpret results; (2) specific information on AS 
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investigations, follow-up, mortality risk; (3) complementary options regarding 
diet, lifestyle, exercise; (4) variety of resources; (5) social support and 
interaction and (6) verification of integrity of information. These requirements 
were reflected in our own FGs. Men who had opted out of AS felt particularly 
strong about this. 
 
 4.1. The clinical team 
The patient relationship with the clinical team is an important variable in 
adherence to healthcare, but it is difficult to assess the nature of this 
interaction and to measure its components. Poor communication is 
traditionally measured in terms of a patients' inability to recall clinician 
instructions, with patients failing to recall between one-third and one-half of 
statements given to them [24]. One FG participant suggested; 
Participant 9 (69y)….”The doctor didn’t even let me sit down, he greeted me 
at the door and said your PSA is fine, see you next year. I had questions, I 
wasn’t encouraged to ask them”…..”after leaving the clinic I couldn’t even 
remember what my PSA level was, I had to call the nurse later that same day.   
‘I was told all I needed to know was that I didn’t need to worry myself – that 
was it, end of conversation”. 
 
Initial selection of AS is strongly associated with multi-disciplinary care [25]. 
However, whilst multidisciplinary clinics are recognised as advantages in 
optimizing AS choice, our FG feedback suggests that variability in personnel 
managing AS leads to specific concerns regarding consistency. This was 
demonstrated through commentaries from several participants (Panel 2). 
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However, the combination of CNS and doctor has been found to benefit men 
with PC. Tarrant [26] and Ream [27] both found that men who had accessed a 
CNS reported a more positive experience of their cancer management. Our 
FGs confirmed that a combination of medical and nursing staff was optimal in 
giving information and supporting men on AS (Panel 1).  
 
4.2 Detailed and consistent information  
Information has a variety of benefits for cancer patients, particularly anxiety 
reduction, improved ability to cope with treatment and better self-care. 
Information can help empower patients. Recognition of the role that support 
and information plays in effective cancer care is not new. In 2002, NICE 
commissioned a report focusing on improving outcomes in urological cancers 
[28]. It recognised that in PC in particular, the appropriate management 
strategy may depend on an individual’s values and attitudes, but should 
include: Information about basic anatomy and pathology, PC and the 
individual variation in its impact and rate of progression, treatment options, 
probability of survival, symptom reduction, risks and potential short- and long-
term effects. Our FGs demonstrated frustration in this respect, describing a 
lack of clarity about that appeared to extend to the medical and nursing team 
(Panel 4).  
 
O’Callaghan [29], Oliffe [5] and Davison [30] found that patients on AS 
became particularly stressed where information given by the clinical team was 
contradictory or inconsistent. Our FG participants also agreed that there was 
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inconsistency, describing a lack of objective, robust information and poor 
descriptors of disease risk and AS (Panel 4).  
 
The FGs discussed both delivery method and type of information and support 
required. All agreed with a 2010 FG study which reported that information on 
the internet was contradictory, limited and difficult to find [31] and therefore a 
dedicated informational source was required.  
 
Many of the men who had dropped out of AS and had later chose to undergo 
radical treatment also remarked on the inconsistent approach to information 
and support services between men offered AS and those undergoing radical 
treatment.  
 
Our group previously reported a significant increase in patient satisfaction 
when offered access to a peer-group educational seminar on radical 
prostatectomy [18]. Galbraith et al. [32] described how this can provide a 
sense of meaning in men's experience of PC. FG participants also suggested 
that mimicking the information and support given to patients in other treatment 
groups may influence behaviour of the health professional team by endorsing 
AS as a valid treatment option [4].  
 
4.3 Diet and lifestyle advice 
A 2015 systematic review of supportive care in PC highlighted self‐care in 
nine papers [33]. Authors discussed empowerment and sense of control that 
comes from self‐care through lifestyle changes. Nanton found that ‘taking an 
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active part in their own health management men were taking control of their 
illness’[34]. This was also described by Oliffe [5] and O’Shaughnessy [35] who 
demonstrated the merits of using strategies similar to men at other stages of 
disease combining ‘living a normal life’ with ‘doing something extra’, e.g. 
dietary or lifestyle changes. This appeared to increase both acceptability and 
adherence to AS and was also described by our FG participants (Panel 5).  
 
5.0 Study limitations 
Our assignment of men to intervention and standard care was not 
randomised, but occurred over consecutive time periods as part of an 
audit/service improvement project where the intervention was the ‘new’ 
standard of care. It is not possible to exclude the influence of clinical practice 
which that may have occurred over this time period e.g initial undersampling 
due to biopsy practitioner experience or learning curve of MRI imaging team. 
This may contribute in part to the higher proportion of men progressing in the 
intervention group despite a significantly higher number of men in GGG1 at 
diagnosis.  
 
Further, the two comparison groups differed in GGG, which may have 
influenced adherence.  However, the differences remained statistically 
significant, even after adjustment for clinical characteristics such as GGG at 
diagnosis. We were however unable to adjust for other recognised 
confounding factors such as marital status, ethnicity and education level. 
 
 15 
18 patients were excluded from the study as they failed to attend the seminar 
intervention. Follow-up with this patient group may have added value in 
reducing future non-attendances. 
 
6.0 Conclusion 
Findings from this study demonstrate that men on AS desire consistency in 
contact with staff, appointments and information. Subsequent evaluation of 
this intervention demonstrates that a peer-group educational seminar, 
delivered by the clinical team in the initial months after starting AS, reduces 
the likelihood of dropping out of AS by 50%. With the trend towards AS in 
LRPC increasing, interventions like this could help assuage the upward drift in 
healthcare costs worldwide. 
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Table 1: Patient characteristics and adherence of study participants in both arms of 
the non-randomised intervention study.  
 
 Standard 
Care 
(Group A) 
Educational 
Seminar 
 (Group B) 
p value 
 n=135 n=120  
Characteristics at AS entry    
Mean Age (SD) 62.4 (6.8) 63.3 (7.4) 0.34 
Mean PSA (SD) 9.2 (7.0) 8.6 (5.3) 0.42 
    
 n (%) n (%)  
Grade    
3+3 42 (31.1) 111 (92.5) 0.001 
3+4 93 (68.9) 9 (7.5)  
DRE assessment    
Benign  47 (34.8) 46 (38.3) 0.56 
T2 77 (57.0) 68 (56.7)  
T3 11 (8.2) 6 (5.0)  
    
 
 
Table 2: Active surveillance outcomes based on intervention group at 1 and 5 years.  
 
Program outcomes Standard 
Care 
(Group A) 
Educational 
Seminar 
 (Group B) 
p-value 
At 1 year:    
Remained in AS program 101 (74.8) 107 (89.2)  
Dropped out due to disease progression 0 0  
Dropped out with no disease progression 34 (25.2) 13 (11.2)  0.003 
    
At 5 years:    
Remained in AS program  62 (45.9) 68 (56.7)  
Dropped out due to disease progression 17 (12.6) 26 (21.7)  0.053 
Dropped out with no disease progression  56 (41.5) 26 (21.7) <0.001 
 
 
  
Table 3. Multivariate logistic regression for odds of dropout for reasons other than 
disease progression. All models were adjusted for age, grade, diagnostic PSA, 
digital rectal examination and clinical stage. 
 
Patient 
characteristics 
(at entry into 
AS) 
At 1 year 
n=253 
By 5 years 
(whole cohort) 
n=253 
By 5 years 
(excl. men with 
disease progression)  
n= 210 
By 5 years  
(excl. men with 
disease progression 
and GGG2) 
n=125 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Educational 
seminar 
    
no 1.00 1.00 1.00  
yes 0.21 (0.09-0.49) 0.25 (0.12-0.51) 0.26 (0.12-0.56) 0.25 (0.11-0.57) 
     
Age 
(continuous) 
1.03 (0.98-1.09) 0.94 (0.91-0.98) 0.93 (0.90-0.98) 0.95 (0.90-1.00) 
     
PSA 
(continuous) 
0.94 (0.88- 1.01) 0.96 (0.52-1.01) 0.98 (0.93-1.04) 0.97 (0.89-1.06) 
     
Gleason Grade 
Group 
    
GGG1 1.00 1.00 1.00 n/a 
GGG2 0.44 (0.20-0.97) 0.49 (0.23-1.00) 0.48 (0.22-1.02) n/a 
     
DRE      
Benign 1.0  1.00 1.00  
T2 0.88 (0.43-1.79) 0.98 (0.54-1.77) 0.93 (0.50-1.72) 0.75 (0.33-1.71) 
T3 1.42 (0.41-4.91) 1.69 ( 0.54-5.32) 3.88 (0.96-15.7) 3.52 (0.51-24.0) 
 
